Medical Disclaimer
PeptideVox is an evidence reference, not medical advice. Nothing on this site authorizes, recommends, or enables you to acquire, possess, or self-administer any compound. Read the following in full before relying on anything published here.
PeptideVox is an evidence reference, not medical advice. Nothing here authorizes you to acquire, possess, or self-administer any compound.
The majority of compounds documented here are not approved by the FDA for human use. Approved drugs are noted explicitly and require a licensed prescriber.
Many peptides are sold strictly “for research use only — not for human consumption.” Purity, identity, and dosing of such products are not regulated or guaranteed.
Several compounds are banned in competitive sport under the WADA Prohibited List. Athletes risk sanction regardless of intent or formulation.
Always consult a qualified, licensed healthcare professional before considering any compound. Individual risk depends on your full medical context.
This content is for informational and educational purposes only · No physician–patient relationship is created · Evidence grades reflect published data as of the stated revision and may change.
No physician–patient relationship
Reading PeptideVox, contacting us, or subscribing to The Evidence Brief does not create a physician–patient, pharmacist–patient, or any other professional relationship. We do not diagnose, treat, prescribe, or provide individualized medical advice. Any decision you make is your own responsibility.
Evidence grades are not endorsements
Our A–D evidence grades describe the strength of the published human evidence for a compound — not its safety, legality, or suitability for you. A high grade does not mean a compound is safe to use, legal to obtain, or appropriate for your situation. An honest “preliminary/unclear” mark means the picture is genuinely unsettled.
High-risk compounds
Some documented compounds carry elevated risk because of unknown long-term safety, unregulated supply, or sport prohibition. These warrant particular caution and qualified clinical oversight:
- Melanotan II. α-MSH analog with reports of nausea, darkening/atypical moles, and blood-pressure changes; no approved human use.
- TB-500 (Thymosin β-4 fragment). Insufficient human safety data; WADA-prohibited; sold strictly as a research chemical.
- BPC-157. No human RCTs; unregulated research-chemical supply with documented purity variance.
- DNP-adjacent “fat-loss” peptides. Any compound marketed for rapid fat loss outside approved GLP-1 therapy warrants extreme caution and clinician oversight.
Regulatory and sport-status references
Verify status directly with the primary authorities before acting:
- U.S. Food & Drug Administration (fda.gov) — approval and compounding status.
- WADA Prohibited List (wada-ama.org) — substances prohibited in sport.
- DailyMed (NIH) — labeling for approved drugs.
No sourcing, no sales
PeptideVox does not sell, source, broker, or facilitate the acquisition of any compound, and we do not link to vendors of unapproved products for human use. We are independent of the companies selling in this space; see our Editorial Policy for our conflict-of-interest standards.
Contact
Questions about this disclaimer, or a safety concern about something we’ve published? Email editor@peptidevox.com.